Tandem Diabetes Care Announces Upcoming Conference Presentations

SAN DIEGO--(BUSINESS WIRE)-- Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a company update at the following investor conferences:

• Citi’s 2026 Unplugged MedTech and Life Sciences Access Day on Thursday, February 26, 2026 at 1:45pm Eastern Time (10:45am Pacific Time),
• TD Cowen 46th Annual Health Care Conference on Wednesday, March 4, 2026 at 9:10am Eastern Time (6:10am Pacific Time), and
• Oppenheimer 36th Annual Healthcare MedTech & Services Conference on Wednesday, March 18, 2026 at 1:20pm Eastern Time (10:20am Pacific Time).

The presentations will be webcast live, and an archive recording will be available for 30 days. The link to the live webcasts and archive will be accessible on Tandem Diabetes Care’s Investor Center website located at http://investor.tandemdiabetes.com in the “Events & Presentations” section.

About Tandem Diabetes Care, Inc.

Tandem Diabetes Care, a global insulin delivery and diabetes technology company, manufactures and sells advanced automated insulin delivery systems that reduce the burden of diabetes management, while creating new possibilities for patients, their loved ones, and healthcare providers. The Company’s pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ+ advanced hybrid closed-loop technology. Tandem Diabetes Care is based in San Diego, California. For more information, visit tandemdiabetes.com.

Tandem Diabetes Care, the Tandem logo, Control-IQ+, Tandem Mobi and t:slim X2 are either registered trademarks or trademarks of Tandem Diabetes Care, Inc. in the United States and/or other countries.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260212737886/en/

Media Contact:
858-366-6900
[email protected]

Investor Contact:
858-366-6900
[email protected]

Source: Tandem Diabetes Care, Inc.

You May Also Be Interested In

• Faraday Future Founder and Global CEO YT Jia Shares Weekly Investor Update: Record Q2 Revenue, EAI Robotics Entering a Phase of Positive-Gross-Margin Volume Growth, and Accelerated Debt Reduction
• Edge Total Intelligence Provides Business Update: Preliminary Second Quarter and First-Half Revenue, Special AGM Matters, and Strategic Growth
• Enhertu® Demonstrated Statistically Significant and Clinically Meaningful Improvement in Progression-Free Survival as First-Line Treatment of Patients with HER2 Mutant Advanced Non-Small Cell Lung Ca